FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...